Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial

Details 詳細情報について

• CRID

  1360857597755419904

• DOI

  10.1016/j.ijrobp.2020.11.026

• ISSN

  03603016

• Web Site

  https://api.elsevier.com/content/article/PII:S036030162034548X?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S036030162034548X?httpAccept=text/plain

• Data Source

  • Crossref